Start here if you're new
what it is
It sells ad software to about 230 clients a year and helps them buy and sell online ads.
how it gets paid
Last year Direct Digital Hldgs made $62M in revenue. Sell-side programmatic platform was the main engine at $28.0M, or 45% of sales.
what just happened
Revenue hit $26M while EPS stayed at -$0.78.
At a glance
C balance sheet — red flag territory — real financial stress
20.9% return on capital — every dollar works hard here
-$140.66 fy2024 eps est
$210M fy2024 rev est
21.2% operating margin
xvary composite: 25/100 — weak
What they do
It sells ad software to about 230 clients a year and helps them buy and sell online ads.
You are not buying a fortress here. You are buying a niche ad shop with 230 clients a year and 79 employees. Programmatic platform → software that buys and sells ads automatically → so what: switching vendors means rebuilding campaigns, not just clicking a button.
How they make money
$62M
annual revenue
Sell-side programmatic platform
$28.0M
Buy-side campaign optimization
$21.7M
Data and media services
$12.3M
The products that matter
buys and sells ad space
Programmatic Advertising Platform
$62M · current disclosed revenue base
it's the legacy business and still the entire disclosed revenue story at $62M after falling from $157M. if this does not stabilize, nothing else on the page matters.
core business
regulatory advisory service
Compliance Practice
launched jan 2026
this practice launched in January 2026, and no revenue contribution is disclosed here yet. your question is simple: does it become a business, or stay a press release with good timing.
unproven
Key numbers
$11M
Long-term debt
You are looking at $11M of debt behind a company with a $2M market cap. The lender has more leverage than the stockholder.
$2M
Market cap
The equity is tiny next to the debt. A $2M market cap leaves almost no room for error.
$62M
Annual revenue
This is the sales base the company has to defend. A $62M business is still small enough for one weak year to hurt.
21.2%
Operating margin
Every $100 of sales leaves $21.20 behind before interest and taxes. That is not a growth story; it is a leakage story.
Financial health
C
strength
- balance sheet grade C — very weak — significant financial distress
- risk rank 5 — safer than 5% of stocks
- price stability 5 / 100
- long-term debt $11M (82% of capital)
C — balance sheet grade and long-term debt are flagged. this stock carries more risk than average.
Total return vs. market
Return history isn't available for DRCT right now.
source: institutional data · return history unavailable
What just happened
missed estimates
Revenue hit $26M while EPS stayed at -$0.78.
Revenue rose 229% vs. prior year, but earnings stayed negative. Gross margin held at 31.1%, so the company sold more, yet it still did not reach profit.
$26.0M
revenue
-$0.78
eps
31.1%
gross margin
the number that mattered
The $26M revenue print matters because it shows the business is still alive, even with negative EPS and a 31.1% gross margin.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the #1 risk is the ad platform keeps shrinking while the compliance practice stays too small to matter.
med
core revenue is still in free fall
Revenue fell 60.3% from $157M to $62M. Because the disclosed business mix is still basically one segment, this is not one division struggling. It is the company shrinking in plain sight.
This leaves 100% of the current $62M revenue base exposed to another weak ad-spend period or customer loss.
med
losses and leverage leave little room for error
TTM EPS sits at -$7.27, long-term debt is $11M, and debt makes up 82% of capital. That combination matters more when your market cap is only about $2M. Equity is the smallest thing in the structure.
If operating losses continue, financing terms matter fast and common shareholders are not negotiating from strength.
med
the listing issue is fixed for now, not solved forever
The company regained Nasdaq compliance on Feb 12, 2026 after a reverse split. That tells you the share-price problem got serious enough to require technical repair, not organic recovery.
If the stock weakens again, listing pressure can return and capital access gets harder when the business already needs stability.
At $62M of revenue, -$7.27 in TTM EPS, and $11M of long-term debt, this company does not have much room for another $95M revenue hole.
source: institutional data · regulatory filings · risk analysis
Pay attention to
revenue
does the top line stop falling
Start with the only question that matters: does revenue stabilize after collapsing from $157M to $62M. If not, the rest of the turnaround language is decoration.
listing
whether Nasdaq compliance holds without another repair job
Compliance was regained on Feb 12, 2026. You want the share price to hold above danger levels on its own, not with more corporate plumbing.
new business
first real proof the compliance practice is contributing
It launched in January 2026. Until management discloses revenue traction, this remains a thesis line rather than an operating result.
earnings
whether losses narrow instead of exploding
Last quarter's small EPS beat did not change the bigger picture. The next-quarter consensus at -$8.80 says the street still expects severe pressure.
Analyst rankings
coverage
thin
in human-speak, there is not enough broad analyst coverage here to build your thesis around target prices or consensus comfort.
next-quarter eps view
-$8.80
Consensus still points to a deeply negative quarter. Analysts are not modeling a clean turnaround yet. They are modeling more pain.
read-through
caution
When coverage is sparse and fundamentals are deteriorating, the number that matters is operating stabilization, not the elegance of the rating label.
source: institutional data
Institutional activity
institutional ownership data for DRCT is being compiled.
source: institutional data
Price targets
3-5 year target range
n/a
n/a
$1
current price
n/a
target midpoint · n/a from current
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive